Cohance Lifesciences Limited
COHANCE
Pozycja w akcjach
#6365
Headquartered in Hyderabad, Cohance Lifesciences Limited operates as a... Headquartered in Hyderabad, Cohance Lifesciences Limited operates as a pharmaceutical enterprise, with primary expertise in contract development and manufacturing (CDMO) services. Its business scope also includes the creation of active pharmaceutical ingredients (APIs) and diverse specialty chemicals. The company, previously known as Suven Pharmaceuticals Limited, underwent a corporate rebranding following its amalgamation with Cohance Lifesciences, a transition officially effective May 1, 2025.
Cena akcji
$5.15
Kapitalizacja rynkowa
$1.97B
Zmiana (1 dzień)
1.99%
Zmiana (1 rok)
-56.53%
Kraj
IN
Handel Cohance Lifesciences Limited (COHANCE)
Kategoria
Healthcare
Zyski dla Cohance Lifesciences Limited (COHANCE)
Zyski w Jun 2025 TTM: $37.76M
Według najnowszych raportów finansowych Cohance Lifesciences Limited, obecny zysk firmy wynosi $37.76M. W roku 2024 firma osiągnęła zysk w wysokości $48.65M, spadek w porównaniu do zysku z roku 2023, który wynosił $68.11M. Wyświetlany zysk to zysk przed odsetkami i podatkami, czyli EBIT.
Historia zysków firmy Cohance Lifesciences Limited od 2019 do 2026
Zyski na koniec każdego roku
| Rok | Zyski | Zmień |
|---|---|---|
| 2026 (TTM) | $37.76M | -6.11% |
| 2025 | $40.21M | -17.35% |
| 2024 | $48.65M | -28.57% |
| 2023 | $68.11M | -22.55% |
| 2022 | $87.95M | 37.66% |
| 2021 | $63.89M | 18.98% |
| 2020 | $53.70M | 136.19% |
| 2019 | $22.73M | 0.00% |
Zyski podobnych firm lub konkurentów
| Firma | Zyski | Różnica w zyskach | Kraj |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| $1.76B | 4,573.48% |
IN
|
